Orange Book product · Brand (NDA)
SELENIOUS ACID
SELENIOUS ACID
At a glance
Aug 30, 2021
Approved
Brand (NDA)
Application
AP
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 30, 2021
4 yr 10 mo ago
Today
Patent 11998565 expires
Listed drug product patent expiration.
Jul 01, 2041
in 15 yr 3 mo
Patent 12150957 expires
Listed method-of-use patent (U-4039) expiration.
Jul 01, 2041
in 15 yr 3 mo
Pharmaceutical detail
Active ingredient
SELENIOUS ACID
Strength
EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
NDA 209379
Product number
003
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2026SELENIOUS ACIDGeneric (ANDA)
ANDA 219472 · KINDOS
- 2025SELENIOUS ACIDGeneric (ANDA)
ANDA 218536 · STIRA
- 2025SELENIOUS ACIDGeneric (ANDA)
ANDA 218661 · CIPLA
- 2025SELENIOUS ACIDGeneric (ANDA)
ANDA 219629 · GLAND
- 2025SELENIOUS ACIDGeneric (ANDA)
ANDA 219633 · ASPIRO
- 2025SELENIOUS ACIDGeneric (ANDA)
ANDA 219547 · SUN PHARM
- 2025SELENIOUS ACIDGeneric (ANDA)
ANDA 218779 · FRESENIUS KABI USA
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11998565 | Jul 01, 2041 | in 15 yr 3 mo | Product |
| 12150957 | Jul 01, 2041 | in 15 yr 3 mo | U-4039 |

